Vaccination for 12+ kids in India likely to start next month

It is a three-dose vaccine which will be administered first on day zero, day 28th and then on the 56th day.

126
Medicine Injection Doctor
picture: Pixabay

Last Updated on September 24, 2021 by The Health Master

All Indian children aged 12 or older will become eligible for C-19 vaccinations from next month, when drug maker Cadila Healthcare launches its ZyCoV-D product, two sources with direct knowledge of the matter told Reuters.

The world’s first DNA-based C-19 vaccine, ZyCoV-D won emergency authorisation from Indian regulators last month. From October, the company, better known as Zydus Cadila, will produce 10 million doses a month.

The vaccine is the only one approved for children in India, which has given a total of 825.9 million doses to adults among its population of nearly 1.4 billion.

ZyCoV-D is a three-dose vaccine which will be administered first on day zero, day 28th and then on the 56th day.

It is a needle-free vaccine administered using The Pharma Jet, a needle free applicator – ‘Tropis’, which ensures painless intradermal vaccine delivery.

Last month, the government’s Department of Biotechnology (DBT) said that the “plug-and-play” technology on which the plasmid DNA platform is based can be easily adapted to deal with mutations in the virus, such as those already occurring.

Covishield

Covaxin

Sputnik V

Modenra

Gujarat launched Online portal for Drug Manufacturing License

Govt begins Anti Dumping probe: Ofloxacin & its intermediates imported…

India to get Johnson & Johnson vaccine doses next month

Covaxin kids trial over: Data to be submitted to DCGI

India and Pharmacy Education: Chapter: 8

Latest Notifications regarding Pharmaceuticals

Telegram
WhatsApp
Facebook
LinkedIn
Google-news

Enter your email address:

Delivered by FeedBurner